Paul D. Rubin, Senior VP Clinical Development & CMO at XOMA Corp (XOMA), sold 5,000 shares at $4.59 ($23K) on 2014-09-15, disclosed to the SEC on 2014-09-16.
Scheduled sale ($23k) by Senior VP Clinical Development & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BIOA | SELL | 2026-02-03 | $139K | — | Filing → |
| BIOA | SELL | 2026-01-06 | $191K | — | Filing → |
| BIOA | SELL | 2025-12-11 | $216K | — | Filing → |